CDMO Cobra Biologics and the Karolinska Institutet have been awarded €3 million emergency funding by Horizon 2020 for research and development and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandem...
Mar 30 2020 Read 99 Times
In This Edition Articles - Meet. Learn. Discover - Ways to tackle the spread of coronavirus using viricidal surface decontamination Features Chromatography - New Wettable Phase Thri...
View all digital editions
Apr 07 2020 Cairo, Egypt
Apr 13 2020 Casablanca, Morocco
Apr 26 2020 Montreal, Quebec, Canada
May 03 2020 Dublin, Ireland
May 12 2020 Oklahoma, USA